Exemestane is better than tamoxifen in years 2-5 after breast cancer
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=449792Documentos Relacionados
- Body mass index, dental caries and sugar intake in 2-5 year-old preschoolers
- MRI may be better than mammography for early detection of breast cancer
- Breast cancer chemoprevention: beyond tamoxifen
- Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer
- Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial